We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Proton Treatment Center Established in Saudi Arabia

By MedImaging International staff writers
Posted on 15 Feb 2012
A new proton treatment facility is being equipped to provide cutting-edge cancer treatment in Riyadh (Saudi Arabia).

Varian Medical Systems (Palo Alto, CA, USA) has booked a USD 77 million order with Saudi Particle Therapy Centre, LLC to equip a new proton therapy facility at the King Fahd Medical Center (Riyadh, Saudi Arabia). Varian will equip the new center with a ProBeam system for five treatment rooms as well as two TrueBeam medical linear accelerators. Equipment delivery and installation is expected to begin in spring 2013 and patient treatments are scheduled to start in late 2014. The agreement will also include a multiyear service contract that should commence as the installation is completed.

“We are honored to have been selected to supply our equipment and software for this prestigious new facility, which will make life-saving proton therapy treatments available for the first time to cancer patients in this region,” said Tim Guertin, Varian’s chief executive officer. “This is an exciting step forward for our Varian Particle Therapy business.”

Proton therapy makes it possible to treat specific types of cancer more precisely and with potentially fewer side effects than with conventional radiation therapy. With proton therapy, the risk of damage to healthy tissues is reduced. The technology can be applied for many of the most common types of cancer and offers advantages when treating tumors close to radiosensitive tissues. In pediatric patients, the risk of developing a new, radiation-induced cancer later in life can be reduced.

“We believe that more and more proton centers will want to employ the full suite of Varian products and technology for radiotherapy and radiosurgery as well as particle therapy for world-class cancer treatments,” said Mr. Guertin. “The combination of these technologies based on 60 years of innovation puts Varian in a unique position to help advance clinical care for patients around the world.”

Varian is currently installing and commissioning its ProBeam system at the Scripps Proton Center near San Diego (CA, USA). The company has also been selected to provide equipment for new proton therapy centers at the University of Maryland (College Park, USA) and in Mestre (Italy). It has been recognized as the preferred provider for a new center at Emory University (Atlanta, GA, USA).

Related Links:

Varian Medical Systems



Diagnostic Ultrasound System
DC-80A
High-Precision QA Tool
DEXA Phantom
Ultrasound Needle Guidance System
SonoSite L25
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices

Channels

General/Advanced Imaging

view channel
CT and fused SPECT-CT images L to R of representative healthy control, pulmonary fibrosis participant & hypersensitivity pneumonitis participant (Image courtesy of SNMMI)

New SPECT/CT Method Differentiates Inflammation from Fibrosis in Interstitial Lung Disease

Interstitial lung disease (ILD) encompasses more than 200 disorders that inflame or scar the lung interstitium and can lead to progressive respiratory failure. Determining whether active inflammation is... Read more

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.